Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Hybridoma and Hybridomics|December 20, 2003
Characterization of monoclonal antibody HTA125 with specificity for human TLR4Rong Wang, Jeffrey Stephens, Michael J LacyJournal of Immunoassay & Immunochemistry|February 19, 2002
Adaptation of commercial immunoassays to analysis of complex biological substancesMichael J Lacy, Rong Wang, Valerie Brookshire, et al.Expert Review of Vaccines|August 6, 2003
Enhancement of antigen-specific immunity via the TLR4 ligands MPL adjuvant and Ribi.529Jay T Evans, Christopher W Cluff, David A Johnson, et al.Trends in Microbiology|October 16, 2002
Taking toll: lipid A mimetics as adjuvants and immunomodulatorsDavid H Persing, Rhea N Coler, Michael J Lacy, et al.International Journal of Toxicology|July 20, 2021
Evaluation of the AV7909 Anthrax Vaccine Toxicity in Sprague Dawley Rats Following Three Intramuscular AdministrationsVeena V Rao, C Steven Godin, Michael J Lacy, et al.Vaccine|August 5, 2017
Correlation between anthrax lethal toxin neutralizing antibody levels and survival in guinea pigs and nonhuman primates vaccinated with the AV7909 anthrax vaccine candidateVladimir Savransky, Jeffry D Shearer, Melicia R Gainey, et al.Vaccine|February 18, 2014
Enhanced early innate and T cell-mediated responses in subjects immunized with Anthrax Vaccine Adsorbed Plus CPG 7909 (AV7909)Jacob T Minang, Jon R Inglefield, Andrea M Harris, et al.Vaccine|June 30, 2022
Use of protective antigen of Bacillus anthracis as a model recombinant antigen to evaluate toll-like receptors 2, 3, 4, 7 and 9 agonists in mice using established functional antibody assays, antigen-specific antibody assays and cellular assaysJon Inglefield, Jason Catania, Andrea Harris, et al.Viruses|September 28, 2021
Influenza Antigens NP and M2 Confer Cross Protection to BALB/c Mice against Lethal Challenge with H1N1, Pandemic H1N1 or H5N1 Influenza A VirusesNutan Mytle, Sonja Leyrer, Jon R Inglefield, et al.Journal of Endotoxin Research|April 17, 2003
Immunostimulatory activity of aminoalkyl glucosaminide 4-phosphates (AGPs): induction of protective innate immune responses by RC-524 and RC-529Jory R Baldridge, Christopher W Cluff, Jay T Evans, et al.Pageof 2